A significant breakthrough in cancer investigation is emerging with the use of nanobodies to re-engage mutated p53. This crucial tumor suppressor protein is frequently disabled in many types of cancer, leading https://socialeweb.com/story7452692/nanobodies-reactivate-the-p53-protein-a-promising-approach-for-malignant-treatment